The global insulin delivery pens market size is calculated at USD 26,412 million in 2024 and is predicted to reach around USD 58,086 million by 2034, expanding at a CAGR of 8.2% from 2024 to 2034.
An insulin delivery pens is an injection device that is used to deliver preloaded insulin into subcutaneous tissues. These pens are one form of insulin therapy given to diabetes patients. This pen offers a more convenient way of taking insulin as it combines the medication and syringe in one handy tool. Compared to syringes, pens come preloaded with insulin. This is also less painful than the traditional way of taking insulin. Many people have reported that they experience almost no pain after their insulin shot. A pen contains 300-900 units of insulin depending upon the device and the concentration of insulin. The increasing demand for a smart insulin delivery product in developing countries is driving the insulin delivery pens market.
The challenge faced with insulin pens is they lower blood sugar levels. It is essential to maintain the blood sugar before start using insulin. The future market is expected to incorporate alternative medications which are cost-effective and implemented with various technologies. Geographically, the North American region is ruling the insulin delivery pens market due to the high prevalence of diabetes, combined with the affordability factor is boosting the market growth.
Published by Ajit Bansod
